Enzolytics Inc (ENZC)

[bigtalan]

Question who will be the ceo of enzolytics after the two subs are sold ?
Charles Cotropia is currently the CEO of Enzolytics12. After the sale of the two subsidiaries, Biogenysis, Inc. (“BGEN”) and Virogentics Inc. (“VIRO”), to Sagaliam Acquisition Corp, Dr. Gaurav Chandra has been appointed the Chief Executive Officer and Chairman of Biogenysis2. Charles Cotropia will continue as the Executive Director of Biogenysis and guide a comprehensive Intellectual Property strategy2. Please note that this information is accurate as of the last update and for the most current information, it’s best to check the official announcements from the company.
By this it seems CC time will be the deal complaiance and deal maker as Executive Director of Biogenysis and guide a comprehensive Intellectual Property strategy. So how will run Enzolytics or will he have dual duty when things are run thru Enzc from the trust and basiclly will be a copy paste until the drugs start proving to work or not. Should they work they will then adjust numbers to pay each company from production fees, then trial fees , and then the big move passing EMA and FDA . higher paids fees for better results until it is a widely used med at which point we hopefully will see money from 2 sources AKA subs for licensing imo GLTA

Learn more


1

finance.yahoo.com
2

nasda